← Company intelligence

Robot maker · registered

Medra

Corporate marketlabCurated record

Medra's Physical AI Scientist platform pairs general-purpose lab robots with an AI reasoning layer that generates hypotheses, designs experiments, and interprets results in a closed loop. Robots are controlled via natural-language commands and execute wet-lab tasks including pipetting, reagent dispensing, and biological sample processing. The stack integrates with customers' existing LIMS and ML infrastructure, enabling continuously-learning experiment cycles across domains such as antibody discovery, protein engineering, gene editing, genomics, and cell biology. As of December 2025, five systems are operating at US partner sites including Genentech and Addition Therapeutics.

HeadquartersSan Francisco, US
Founded2021
Corporate funding$63M
Team11-50
Deployments2
Open roles10
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeries A
FoundersMichelle Lee (CEO & Founder)
Regions servedUS
Countries deployedNot listed
Service footprintNot listed
Last reviewed2026-07-05
MX

Robot models

Specifications remain vendor-claimed

Machinelab

Medra Lab 001

  • World's first Physical AI Scientist platform — an autonomous system that designs, executes, and learns from life sciences experiments in a closed loop

    Vendor-described capability

    Claim source
DP

Deployment log

Announced and cited only

AnnouncedCustomerSiteCountryCountEvidence
2025-12-11GenentechlabUSNot disclosedAnnouncement
2025-12-11Addition TherapeuticslabUSNot disclosedAnnouncement
CA

Funding history

Publicly announced rounds

Investors on recordHuman CapitalLux CapitalNeoNFDGMenlo Ventures776
HR

Hiring signal

Public job board · 2026-07-13

Open roles10

Hiring is an operating signal, not deployment evidence. Roles are refreshed from the company’s public careers system.

TL

Company timeline

Milestones and announcements

2025-12-11Raised $52M Series A led by Human Capital; announced partnership with Genentech with five deployed systems running at US partner sitesPharmaLive
2025-09-12Emerged from stealth with $11M seed funding to automate life science laboratoriesEndpoints News
SC

Source ledger

5 unique public sources